T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$7.49B |
| 2 |
Micron Technology
MU
|
+$6.62B |
| 3 |
Lam Research
LRCX
|
+$3.45B |
| 4 |
Applied Materials
AMAT
|
+$3.03B |
| 5 |
Advanced Micro Devices
AMD
|
+$2.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$12.1B |
| 2 |
Apple
AAPL
|
+$11.6B |
| 3 |
Amazon
AMZN
|
+$3.54B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.07B |
| 5 |
Keysight
KEYS
|
+$1.82B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.73% |
| 2 | Healthcare | 11.3% |
| 3 | Financials | 10.32% |
| 4 | Communication Services | 9.66% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Donaldson
DCI
$10.1B
| $9.84M | ﹤0.01% |
109,613
+7,792
| +8% | +$670K |
|
1327
Zions Bancorporation
ZION
$9.22B
| $9.81M | ﹤0.01% |
141,833
+8,690
| +7% | +$548K |
|
1328
Molson Coors Class B
TAP
$6.76B
| $9.78M | ﹤0.01% |
251,030
+13,450
| +6% | +$562K |
|
1329
Flowserve
FLS
$9.42B
| $9.77M | ﹤0.01% |
131,706
+10,804
| +9% | +$822K |
|
1330
Macerich
MAC
$6.4B
| $9.72M | ﹤0.01% |
385,841
+86,378
| +29% | +$1.94M |
|
1331
Quaker Houghton
KWR
$2.76B
| $9.69M | ﹤0.01% |
61,005
+6,260
| +11% | +$880K |
|
1332
Brookfield Asset Management
BAM
$71.1B
| $9.69M | ﹤0.01% |
215,993
-287
| -0.1% | -$13.6K |
|
1333
Glacier Bancorp
GBCI
$5.74B
| $9.68M | ﹤0.01% |
187,636
+28,939
| +18% | +$1.39M |
|
1334
Immuneering
IMRX
$269M
| $9.66M | ﹤0.01% |
1,936,076
+106,888
| +6% | +$541K |
|
1335
Allogene Therapeutics
ALLO
$563M
| $9.65M | ﹤0.01% |
4,639,283
-741,619
| -14% | -$1.63M |
|
1336
Ryder
R
$8.97B
| $9.65M | ﹤0.01% |
36,579
+1,277
| +4% | +$312K |
|
1337
Post Holdings
POST
$3.39B
| $9.63M | ﹤0.01% |
109,121
+13,610
| +14% | +$1.33M |
|
1338
NNN REIT
NNN
$7.95B
| $9.63M | ﹤0.01% |
206,991
+39,683
| +24% | +$1.77M |
|
|
GTLS
1339
DELISTED
Chart Industries
GTLS
| $9.57M | ﹤0.01% |
45,820
-4,787
| -9% | -$994K |
|
1340
Alto Neuroscience
ANRO
$1.05B
| $9.46M | ﹤0.01% |
358,279
-12,929
| -3% | -$299K |
|
1341
MediWound
MDWD
$180M
| $9.43M | ﹤0.01% |
641,075
-68,772
| -10% | -$1.09M |
|
1342
Cullen/Frost Bankers
CFR
$9.72B
| $9.41M | ﹤0.01% |
60,916
+3,683
| +6% | +$523K |
|
1343
American Financial Group
AFG
$11.5B
| $9.4M | ﹤0.01% |
67,195
+4,364
| +7% | +$579K |
|
|
NUVL
1344
DELISTED
Nuvalent
NUVL
| $9.35M | ﹤0.01% |
75,740
-1,980,393
| -96% | -$213M |
|
1345
Silicon Laboratories
SLAB
$7.38B
| $9.29M | ﹤0.01% |
42,521
+7,080
| +20% | +$1.53M |
|
1346
Fox Class B
FOX
$23.8B
| $9.29M | ﹤0.01% |
198,358
-1,118
| -0.6% | -$62.1K |
|
1347
Korn Ferry
KFY
$3.89B
| $9.29M | ﹤0.01% |
139,515
+25,406
| +22% | +$1.72M |
|
1348
Commercial Metals
CMC
$7.13B
| $9.29M | ﹤0.01% |
148,030
+22,137
| +18% | +$1.56M |
|
1349
Fortune Brands Innovations
FBIN
$4.59B
| $9.28M | ﹤0.01% |
169,056
-3,716
| -2% | -$149K |
|
1350
Aecom
ACM
$7.65B
| $9.27M | ﹤0.01% |
132,846
-84,795
| -39% | -$6.49M |
|
Similar funds
T. Rowe Price Associates's Q2 2026 Portfolio in Review
As of Q2 2026, T. Rowe Price Associates held 3,356 positions worth $999B, up 16% from $865B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2026 filing shows 224 new, 2,237 increased, 645 reduced and 116 closed positions. Its largest new stake was SpaceX: 10,709,016 shares worth $1.83B. The largest sale was Microsoft, an estimated $12.1B.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2026 buy was SpaceX: 10,709,016 shares worth $1.83B.
- T. Rowe Price Associates added most to Alphabet (Google) Class A in Q2 2026, an estimated $7.49B increase.
- T. Rowe Price Associates's biggest Q2 2026 reduction was Microsoft, cutting an estimated $12.1B.
- T. Rowe Price Associates fully exited Sibanye-Stillwater in Q2 2026, selling an estimated $40.4M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $999B portfolio in Q2 2026.
- T. Rowe Price Associates opened 224 new positions and closed 116 in Q2 2026.
- T. Rowe Price Associates's portfolio value rose 16% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.